AMANDA MEYERRICKS: Open Payments
NPI 1982356911 · RONKONKOMA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,901 in 79 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $926 · 2025 $1,901
Food & beverage: $1,901
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $569 |
| ARGENX US, INC. | 8 | $234 |
| HARMONY BIOSCIENCES LLC | 6 | $184 |
| Lundbeck LLC | 8 | $166 |
| UCB, Inc. | 6 | $130 |
| SCILEX PHARMACEUTICALS INC. | 5 | $114 |
| Axsome Therapeutics, Inc. | 5 | $110 |
| Lilly USA, LLC | 3 | $75 |
| PFIZER INC. | 3 | $58 |
| Neurocrine BioSciences, Inc. | 2 | $58 |
Products named: QULIPTA, VYVGART, UBRELVY, WAKIX, VYEPTI, BOTOX, ZTLido, Symbravo.
Industry payments across NY — which companies pay providers there.
